Kahn Swick & Foti continues Inspire Medical Systems investigation after 2025 guidance cut

The law firm said its probe centers on whether Inspire officers or directors breached fiduciary duties after the company reduced 2025 earnings guidance from $2.20-$2.30 to $0.40-$0.50 per share.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.